Sanara Q2 revenue up 28% to record $20.2M; net loss widens to $3.5M

Sanara MedTech Inc.

2024-Q2 EPS reported -$0.62 revenue$38,695,461

Revenue $20.2M, +28% YoY; eleventh consecutive record revenue quarter.
Net loss $3.5M vs $1.9M; Adjusted EBITDA $0.6M vs ($0.3M).
Secured $55M non-dilutive term loan from CRG; $15M drawn, up to $39.8M additional.
New GPO agreement adds over 1,000 contracted facilities; 300+ distributors, +70 since Jan.
Appointed Jake Waldrop as COO and Tyler Palmer as Chief Corporate Development & Strategy Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.